HEMOPHILIA

This early-stage study tested the safety of a new experimental drug called MG1113 for people with severe hemophilia. Fifteen adult male patients received weekly injections for eight weeks while researchers carefully monitored for side effects. The main goal was to understand how …

This study tested a special type of light strength training, called blood flow restriction training, for adults with moderate or severe hemophilia. The goal was to see if this gentle exercise program was safe and could improve muscle strength, reduce pain, and enhance quality of …

This study tested whether a 6-week program of hands-on therapy and structured exercises could help adults with hemophilia. Researchers wanted to see if it improved their balance, walking ability, joint health, and pain during activity. Thirty-five participants were split into two…

This study tested if a lower-cost version of a platelet-rich plasma (PRP) injection could safely help manage painful, swollen joints caused by bleeding into them (hemarthropathy), a common problem for people with conditions like hemophilia. Fourteen participants with knee, ankle,…

This study aimed to understand why people with hemophilia experience chronic joint pain, even when they're not actively bleeding. Researchers examined 146 adults with hemophilia and knee/ankle joint damage to measure how their nervous systems process pain. They used questionnaire…

This study aimed to understand if children with hemophilia have different lung function, exercise capacity, and physical activity levels compared to healthy children. Researchers measured breathing tests, fitness on a stationary bike, posture, and activity questionnaires in 34 bo…

This study looked at how COVID-19 lockdowns in France impacted people with long-term health conditions like heart disease, multiple sclerosis, and cancer. Researchers followed over 1,300 patients to see if lockdowns changed their medication use, lifestyle habits, and access to me…